Progressive Care Inc (RXMD)

[DCorleone]

RXMD 01/05/2019 Tic Toc Tic Toc, The Shares run up the Float...........

On January 5, 2018, the Board of Directors approved a grant of restricted common stock to
certain employees of the Company and PharmCo, LLC, which is the wholly owned subsidiary of
Progressive Care, Inc. These shares carry a 12 month vesting period for all recipients. The
certificates will be retained by the Company and will be distributed upon completion of the
vesting periods. Certificates were received by the Company on March 27, 2018. Pursuant to this
board resolution, shares were issued in the name of the following officers/directors/affiliates
whose interests have now changed as a result of the issuance of shares.

Armen Karapetyan
Control Person
Shares previously owned: 21,523,016
Shares issued: 20,000,000
Common Shares Beneficially Owned as of March 30, 2018: 41,532,016 – 10.03%
Preferred Shares Beneficially Owned: 51 – 100%

Shital Parikh Mars
Chief Executive Officer
Shares previously owned: 2,000,000
Shares issued: 10,000,000
Common Shares Beneficially Owned as of March 30, 2018: 12,000,000 – 2.90%

Alan Jay Weisberg
Chief Financial Officer
Shares previously owned: 1,127,091
Shares issued: 5,000,000
Common Shares Beneficially Owned March 30, 2018: 6,127,091 – 1.48%

Oleg Firer
Director
Shares previously owned: 500,000
Shares issued: 500,000
Common Shares Beneficially Owned March 30, 2018: 1,000,000 – 0.24%

Jervis Bennett Hough
Director
Shares previously owned: 500,000
Shares issued: 500,000
Common Shares Beneficially Owned March 30, 2018: 1,000,000 – 0.24%